English (United Kingdom)Thai (ภาษาไทย)

Tentative result for EQAI 2017

TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM 

 

TRIAL 01-17-4 

Control material NO.

01-17-4-1

01-17-4-2

01-17-4-3

01-17-4-4

Non treponemal test

Non-ReactiveNon-Reactive

Reactive

Reactive

Treponemal test

NS

NS

Reactive

Reactive

 
 

 

TENTATIVE DESIGNATED RESPONSE FOR HEPATITIS B VIRUS
SEROLOGY PROGRAM
 
 

 TRIAL 02-17-4 

 

Control material NO.

02-17-4-1

02-17-4-2

02-17-4-3

02-17-4-4

HBsAg

NEGATIVE
0.58± 0.11(ECLIA)

NEGATIVE
0.56± 0.11(ECLIA)

POSITIVE
1,519.55± 134.58
(ECLIA)

POSITIVE
2,997.86±236.37(ECLIA)

antiHBs
(all methods)
(mIU/ml)

POSITIVE
318.27 ±81.58

POSITIVE
255.13 ± 53.42

NEGATIVE
0.69± 1.02

NEGATIVE
0.60±0.85

antiHBc

POSITIVE

POSITIVE

POSITIVE

POSITIVE

HBeAg

NEGATIVE

NEGATIVE

NEGATIVE

NEGATIVE

antiHBe

POSITIVE

POSITIVE

POSITIVE

POSITIVE

 
 
 
TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM 
 

 TRIAL 01-17-3

Control material NO.

01-17-3-1

01-17-3-2

01-17-3-3

01-17-3-4

Non treponemal test

Reactive

Reactive

Reactive

Reactive

Treponemal test

Reactive

Reactive

Reactive

Reactive

 
 
 
TENTATIVE DESIGNATED RESPONSE FOR HEPATITIS B VIRUS
SEROLOGY PROGRAM
 
 

TRIAL 02-17-3 

 

Control material NO.

02-17-3-1

02-17-3-2

02-17-3-3

02-17-3-4

HBsAg

NEGATIVE
0.59± 0.13(ECLIA)

NEGATIVE
0.56± 0.12(ECLIA)

POSITIVE
7,877.87± 599.28
(ECLIA)

POSITIVE
9,764.01±686.08(ECLIA)

antiHBs
(all methods)
(mIU/ml)

POSITIVE
599.69 ±155.04

POSITIVE
122.74 ± 40.03

NEGATIVE
0.58± 0.96

NEGATIVE
0.44±0.70

antiHBc

NEGATIVE

POSITIVE

POSITIVE

POSITIVE

HBeAg

NEGATIVE

NEGATIVE

NEGATIVE

NEGATIVE

antiHBe

NEGATIVE

POSITIVE

POSITIVE

POSITIVE

 
 
 
TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM
 

 TRIAL 01-17-2 

 
 

Control material NO.

01-17-2-1

01-17-2-2

01-17-2-3

01-17-2-4

Non treponemal test

Non-

Reactive

Non-

Reactive

Reactive

Reactive

Treponemal test

Reactive

Reactive

Reactive

Reactive

 
 
   
  
TENTATIVE DESIGNATED RESPONSE FOR HEPATITIS B VIRUS
SEROLOGY PROGRAM
 
 

TRIAL 02-17-2

 
  

Control material NO.

02-17-2-1

02-17-2-2

02-17-2-3

02-17-2-4

HBsAg

NEGATIVE
0.66± 0.40(ECLIA)

POSITIVE
4510.91± 1139.26(ECLIA)

POSITIVE
1131.69± 483.88
(ECLIA)

POSITIVE
6287.84±1910.80(ECLIA)

antiHBs
(all methods)
(mIU/ml)

POSITIVE
490.34 ±78.20

NEGATIVE
1.72 ± 1.40

NEGATIVE
2.89± 2.68

NEGATIVE
1.98±1.90

antiHBc

POSITIVE

POSITIVE

POSITIVE

POSITIVE

HBeAg

NEGATIVE

POSITIVE

POSITIVE

POSITIVE

antiHBe

POSITIVE

NEGATIVE

NEGATIVE

NEGATIVE

 
   
   
  
TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM
 
 

TRIAL 01-17-1

 
 

Control material NO.

01-17-1-1

01-17-1-2

01-17-1-3

01-17-1-4

Non treponemal test

NS

Reactive

Reactive

Reactive

Treponemal test

Reactive

Reactive

Reactive

Reactive

 
   
TENTATIVE DESIGNATED RESPONSE FOR HEPATITIS B VIRUS
SEROLOGY PROGRAM
   
 

TRIAL 02-17-1

 
 

Control material NO.

02-17-1-1

02-17-1-2

02-17-1-3

02-17-1-4

HBsAg

POSITIVE
1053± 175.24(ECLIA)

POSITIVE
847.77± 105.32(ECLIA)

POSITIVE
879.56± 114.20(ECLIA)

NEGATIVE
0.23±0.10(ECLIA)

antiHBs
(all methods)
(mIU/ml)

NEGATIVE
0.5 ±1.49

NEGATIVE
0.50 ± 1.47

NEGATIVE
0.53± 1.47

POSITIVE
161.37±161.85

antiHBc

POSITIVE

POSITIVE

POSITIVE

POSITIVE

HBeAg

NEGATIVE

NEGATIVE

NEGATIVE

NEGATIVE

antiHBe

POSITIVE

POSITIVE

POSITIVE

NEGATIVE

 

Copyright © 2010 Faculty of Medical Technology, Mahidol University. All Rights Reserved. Download Internet Explorer 8 Top